C07K 16/44
Against material not provided for elsewhere
Official title: against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids}
C07K16/44 (Against material not provided for elsewhere) appears on 1,686 US grants and 2,442 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,686
- Published applications
- 2,442
- Assignees
- 1,058
- Inventors
- 4,437
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 6 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 8 | 0 |
| 1990 | 2 | 0 |
| 1991 | 9 | 0 |
| 1992 | 16 | 0 |
| 1993 | 19 | 0 |
| 1994 | 18 | 0 |
| 1995 | 18 | 0 |
| 1996 | 23 | 0 |
| 1997 | 54 | 0 |
| 1998 | 34 | 0 |
| 1999 | 37 | 0 |
| 2000 | 25 | 0 |
| 2001 | 27 | 12 |
| 2002 | 17 | 32 |
| 2003 | 31 | 58 |
| 2004 | 16 | 60 |
| 2005 | 19 | 74 |
| 2006 | 29 | 75 |
| 2007 | 41 | 61 |
| 2008 | 35 | 61 |
| 2009 | 34 | 81 |
| 2010 | 43 | 86 |
| 2011 | 43 | 88 |
| 2012 | 36 | 95 |
| 2013 | 52 | 91 |
| 2014 | 75 | 123 |
| 2015 | 71 | 117 |
| 2016 | 88 | 126 |
| 2017 | 83 | 127 |
| 2018 | 77 | 108 |
| 2019 | 77 | 117 |
| 2020 | 85 | 134 |
| 2021 | 84 | 141 |
| 2022 | 54 | 118 |
| 2023 | 66 | 119 |
| 2024 | 72 | 133 |
| 2025 | 93 | 121 |
| 2026 | 45 | 84 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Humanized single-domain antibodies binding to epitope tags25 Aug 2026US 12,715,936 B2Nano Tag Biotechnologies GmbH
- Bi-specific fusion proteins25 Aug 2026US 12,715,937 B2Silver Creek Pharmaceuticals, Inc.
- Multi-specific antibodies and methods of using thereof18 Aug 2026US 12,709,647 B2Systimmune, Inc.
- Methods of identifying protein binding sites on RNA18 Aug 2026US 12,709,770 B2The Regents of the University of California
- Antibodies binding C5 and uses thereof11 Aug 2026US 12,703,763 B2Biosion Inc.
- Engineered Antibodies and Uses Thereof8 Oct 2026US 2026/0308277 A1Invitrogen Bioservices India Private Limited
- Chimeric engulfment receptor molecules and methods of use8 Oct 2026US 2026/0308281 A1Cero Therapeutics Holdings, Inc.
- Cell surface engineered of tailored therapeutic gene delivery8 Oct 2026US 2026/0308617 A1The Children’s Hospital of Philadelphia
- Diphenoxylate artificial hapten, diphenoxylate artificial antigen, preparation methods therefor, and use thereof1 Oct 2026US 2026/0297030 A1Hangzhou Alltest Biotech Co., Ltd
- Methods of treating oxidized phosphatidylcholine-associated diseases1 Oct 2026US 2026/0297217 A1
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,541US 5,661,016 AGenPharm International, Inc. · 1997